Biological E reduces slashes price of its Covid vaccine Corbevax
₹250 from ₹840 a dose, inclusive of GST, for private vaccination centres. The company in a statement said that the reduction in price will result in end users paying a price of ₹400 a dose which will include the taxes and administration charges.
Previously, in private vaccination centres the overall cost to end users of the vaccine was ₹990 a dose, including taxes and administration charges, it added. "BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children against the virus," the company said.
Biological E. has developed India’s first Indigenous Sub-unit COVID-19 against the novel coronavirus. Last month the company said that it has manufactured 30 crore doses of Corbevax and have already supplied nearly 10 crore doses to the Government of India.
Currently, over 3 crore doses of Corbevax have been administered in children between 12-15 years of age. In March this year when the inoculation of children in the age group of 12 to 14 years against COVID-19 commenced in the country, Corbevax vaccine was used and its price was fixed at ₹145 for government vaccination programme.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|